retatrutide parkinson clinical trial A Big Week for GLP-1 Drugs - by Eric Topol retatrutide parkinson's disease clinical trial

Plain gelatin water tasted like punishment by day 10

GLP-1 agonists address the specific appetite and metabolic dysregulation that occurs during menopause by restoring satiety signals and improving insulin sensitivity

2021;29(7):679693 e676

Tirzepatide effectively attenuated the rewarding properties of alcohol as measured through locomotor stimulation, conditioned place preference, and accumbal dopamine release

Many GLP-1 users find this hybrid approach (cooking some meals, using prepared meals for others) works best

The appeal of a lower price is understandable, especially when retatrutide costs significantly more than simpler peptides